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Abstract: The exon junction complex (EJC) that is deposited onto spliced mRNAs upstream of
exon–exon junctions plays important roles in multiple post-splicing gene expression events, such as
mRNA export, surveillance, localization, and translation. However, a direct role for the human EJC
in pre-mRNA splicing has not been fully understood. Using HeLa cells, we depleted one of the EJC
core components, Y14, and the resulting transcriptome was analyzed by deep sequencing (RNA-Seq)
and confirmed by RT–PCR. We found that Y14 is required for efficient and faithful splicing of a
group of transcripts that is enriched in short intron-containing genes involved in mitotic cell-cycle
progression. Tethering of EJC core components (Y14, eIF4AIII or MAGOH) to a model reporter
pre-mRNA harboring a short intron showed that these core components are prerequisites for the
splicing activation. Taken together, we conclude that the EJC core assembled on pre-mRNA is critical
for efficient and faithful splicing of a specific subset of short introns in mitotic cell cycle-related genes.
Keywords: exon junction complex (EJC); Y14; pre-mRNA splicing; mitotic cell-cycle
1. Introduction
Pre-mRNA splicing, the correct and precise removal of introns is an essential part of gene
expression in eukaryotes. The spliceosome, which catalyzes pre-mRNA splicing, deposits a
multi-protein complex, called the exon junction complex (EJC), onto spliced mRNAs ~24 nucleotides
(nt) upstream of exon–exon junctions in a sequence-independent manner (reviewed in [1]). The EJC
is composed of four core components, eIF4AIII, Y14, MAGOH and MLN51, and many proteins
that are weakly associated with the EJC core, termed EJC peripheral factors. In metazoans, the EJC
core functions as a binding platform for more than a dozen peripheral protein factors that allow
it to regulate multiple subsequent post-splicing gene expression events including mRNA export,
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mRNA localization, translation, and mRNA surveillance via nonsense-mediated mRNA decay (NMD).
The well-characterized representatives of EJC peripheral factors are Aly/REF, UAP56, NXF1/TAP and
NXT1/p15 that are involved in mRNA export, and UPF1, UPF2, UPF3 and SMG6 that are essential
factors for NMD.
Notably, the EJC peripheral factors also include several splicing regulatory proteins such as
RNPS1, ACINUS, SAP18 and PININ (reviewed in [1]). RNPS1 was originally identified as a general
splicing activator in vitro and as a regulator of alternative splicing in vivo [2–4]. RNPS1 also has roles
in the 3’-end processing, translation and NMD [5–7]. It is known that ACINUS is involved in apoptosis,
RNA processing and transcriptional regulation [8,9]. SAP18 was identified as a component of the Sin3
histone deacetylase complex that enhances transcriptional repression [10], but SAP18 is also capable of
modulating alternative splicing via its ubiquitin-like fold [11]. PININ was originally identified as a
desmosome-associated protein [12], but it also functions as a splicing co-activator [13]. RNPS1, SAP18,
and ACINUS were identified as a ternary complex termed the apoptosis and splicing-associated
protein (ASAP) complex [8]. Moreover, a recent structural analysis showed that RNPS1 and SAP18
interact with PININ, forming another ternary complex, PSAP [14]. However, it still remains unclear
whether these ternary complexes are associated with the EJC core. Interestingly, it was shown that
core and peripheral EJC components regulate alternative splicing of BCL-X pre-mRNA through its
binding to a cis-acting element, whose activity is distinct from the established EJC function [15]. All this
evidence suggested that the EJC core is capable of recruiting various splicing regulators and that these
interactions may indeed regulate pre-mRNA splicing.
In this study, we performed an siRNA-mediated depletion of an EJC core factor, Y14, followed by
whole transcriptome analysis to identify the introns affected by Y14. Intriguingly, we found that Y14
plays a critical role in the efficient and faithful splicing of a particular group of transcripts including
short introns, many of which are involved in mitotic cell-cycle progression. Accordingly, knockdown
of Y14 induced G2/M arrest and apoptosis in HeLa cells. Furthermore, a tethering assay of the EJC
core components (eIF4AIII, Y14 or MAGOH) demonstrated that the formation of the EJC core onto
pre-mRNA (not onto mRNA) enhances splicing. These results provide a considerable insight into the
EJC-mediated splicing fine-tuning mechanism for short introns in functionally related genes.
2. Results
2.1. The EJC Core Component Y14 Is Required for Efficient and Faithful Splicing of a Subset of Transcripts
To investigate whether the EJC is implicated in pre-mRNA splicing, we performed a
deep-sequencing analysis of transcriptome in Y14-knockdown HeLa cells, i.e., RNA-Seq analysis.
DNA libraries were prepared with poly(A)+ mRNA isolated from total RNA (DNase-digested), which
is derived from HeLa cells treated with Y14 siRNA or control siRNA. The resulting reads were aligned
to the human genome reference sequence using the TopHat mapping tool. To examine the splicing
efficiency, we calculated the intron retention rate (IRR) from the RNA-Seq data sets from control siRNA-
and Y14 siRNA-treated HeLa cells as described in Supplementary Experimental Procedures.
As a result, we found that 626 introns in 483 genes were retained at higher levels (IRR high score
group) in Y14-knockdown HeLa cells (Supplementary Table S1A,B). In contrast, 335 introns in 250 genes
were retained at lower levels (IRR low score group) in Y14-knockdown HeLa cells (Supplementary
Table S1C,D). We selected 15 introns, and the RNA-Seq data were validated by RT–PCR (Figure 1A; 11 introns
from the IRR high score group, two introns from the IRR low score group, and two introns as controls).
We also identified five introns of which splicing was moderately inhibited in Y14-knockdown HeLa cells
according to our RNA-Seq data sets (Figure 1B). These results indicated that the splicing efficiency of
some specific introns is enhanced by Y14, but splicing of other specific introns is repressed. Moreover,
we found that knockdown of another EJC core component, eIF4AIII, has similar splicing repressive
effect on Y14-knockdown responsive introns (Supplementary Figure S1). Taken together, we conclude
that the EJC core selectively affects the splicing efficiency of some particular, but not all, introns.
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Figure 1. A subset of introns are retained upon Y14 knockdown. RNA-Seq-based selection was 
performed with total RNAs that were prepared from control siRNA- or Y14 siRNA-treated HeLa 
cells. The selected representative introns were analyzed by RT–PCR (see Supplementary Table S4 for 
primer sequences). All PCR products were subcloned and the sequences were verified. The 
schematic representation on the right of each panel indicates the corresponding unspliced- and 
spliced-products. (A) The upper and lower left panels represent the IRR high score group (log 2 [Y14 
IRR/Ctl IRR] ≥ 1.0, p < 0.05) and low score group (log 2 [Y14 IRR/Ctl IRR] ≤ −1.0, p < 0.05), respectively. 
The lower right panel shows the control group with CDK1 (E5–E6) and ACTG1 (E3–E4) pre-mRNAs; 
their splicing efficiencies were not changed either in Y14 siRNA- or in control siRNA-treated cells; 
and (B) these five selected introns were categorized in the following IRR score group (0 < log 2 [Y14 
IRR/Ctl IRR] < 1, p < 0.05 or log 2 [Y14 IRR/Ctl IRR] ≥ 1.0, p > 0.05), in which RT–PCR analyses showed 
apparent intron retention in sY14 siRNA-treated cells. 
To examine the role of the EJC in efficient pre-mRNA splicing, we focused on a set of retained 
introns in Y14-knockdown HeLa cells. At first, we investigated the transcripts from the AURKB 
(Aurora B kinase), MDM2 (murine double minute2) and ACTG1 (actin γ1) genes in Y14-knockdown 
cells. We tested whether the intron retention would be accompanied by the aberrant splicing, 
generating the abnormal mRNAs. Interestingly, Y14 knockdown resulted in the reduction of intact 
mRNAs accompanied by the production of several abnormal mRNAs from the MDM2 and AURKB 
genes (Figure 2A,B), while only the full-length transcript from the ACTG1 gene was detected in 
Y14-knockdown HeLa cells (Figure 2C). Sequencing of truncated transcripts for the MDM2 and 
AURKB genes confirmed that aberrant splicing and exon skipping occurred in Y14-knockdown 
HeLa cells (Figure 2A,B). These abnormal transcripts might be translated into the proteins that could 
be deleterious for cells, although we found the amounts of MDM2 and AURKB proteins were largely 
unaffected (Figure 2D). These results suggested that the EJC contributes to the efficient and proper 
pre-mRNA splicing of a subset of transcripts. 
Figure 1. A subset of introns are retained upon Y14 knockdown. RNA-Seq-based selection was
performed with total RNAs that were prepared from control siRNA- or Y14 siRNA-treated HeLa
cells. The selected representative introns were analyzed by RT–PCR (see Supplementary Table S4 for
primer sequences). All PCR products were subcloned and the sequences were verified. The schematic
representation on the right of each panel indicates the corresponding unspliced- and spliced-products.
(A) The upper and lower left panels represent the IRR high score group (log 2 [Y14 IRR/Ctl IRR] ě 1.0,
p < 0.05) and low score group (log 2 [Y14 IRR/Ctl IRR] ď ´1.0, p < 0.05), respectively. The lower right
panel shows the control group with CDK1 (E5–E6) and ACTG1 (E3–E4) pre-mRNAs; their splicing
efficiencies were not changed either in Y14 siRNA- or in control siRNA-treated cells; and (B) these five
selected introns were categorized in the following IRR score group (0 < log 2 [Y14 IRR/Ctl IRR] < 1,
p < 0.05 or log 2 [Y14 IRR/Ctl IRR] ě 1.0, p > 0.05), in which RT–PCR analyses showed apparent intron
retention in sY14 siRNA-treated cells.
To examine the role of the EJC in efficient pre-mRNA splicing, we focused on a set of retained
introns in Y14-knockdown HeLa cells. At first, we investigated the transcripts from the AURKB
(Aurora B kinase), MDM2 (murine double minute2) and ACTG1 (actin γ1) genes in Y14-knockdown
cells. We tested whether the intron retention would be accompanied by the aberrant splicing,
generating the abnormal mRNAs. Interestingly, Y14 knockdown resulted in the reduction of intact
mRNAs accompanied by the production of several abnormal mRNAs from the MDM2 and AURKB
genes (Figure 2A,B), while only the full-length transcript from the ACTG1 gene was detected in
Y14-knockdown HeLa cells (Figure 2C). Sequencing of truncated transcripts for the MDM2 and
AURKB genes confirmed that aberrant splicing and exon skipping occurred in Y14-knockdown HeLa
cells (Figure 2A,B). These abnormal transcripts might be translated into the proteins that could be
deleterious for cells, although we found the amounts of MDM2 and AURKB proteins were largely
unaffected (Figure 2D). These results suggested that the EJC contributes to the efficient and proper
pre-mRNA splicing of a subset of transcripts.
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Figure 2. Y14 is required for faithful splicing of MDM2 and AURKB pre-mRNAs. (A–C) HeLa cells 
were transfected with control siRNA or Y14 siRNA and obtained total RNAs at 48 h post-transfection 
were analyzed by RT–PCR using primer sets for MDM2 (A), AURKB (B), and ACTG1 (C) transcripts. 
The RT–PCR products were subcloned and the sequences were verified. The schematic 
representation on the right indicates the corresponding mRNA products. Black boxes represent 
full-length exons and grey boxes represent truncated exons generated by alternative splice site usage; 
and (D) Western blot analysis of whole cell extracts of control siRNAs- or Y14 siRNA-treated HeLa 
cell using anti-Y14, anti-MDM2, anti-AURKB, and anti-TUBULIN antibodies. 
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It has been reported that the EJC co ponents play an i portant role in proper splicing of
transcripts containing long introns (>1000 nt) in Drosophila [16,17]. To exa ine if this is the case in
a alian cells, e investigated the size distribution of the Y14-knockdo n responsive introns.
Re arkably, 52.4% (328/626) of the introns in the IRR high score group, in which splicing was strongly
inhibited in Y14-knockdown cells, were shorter than 500 nt (Figure 3A and Supplementary Table S2).
The ratios of the shorter introns (<500 nt) in the IRR low score group and a control Ref-seq group
were 37.0% (124/335) and 25.1% (34422/137116), respectively, which are significantly lower than the
ratio in the IRR high score group. These results suggest that the EJC has a critical role in efficient
splicing of pre-mRNAs with short introns in mammals, in stark contrast to the EJC-sensitive splicing
defect of long introns in Drosophila.
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Figure 3. A majority of retained introns in Y14 knockdown cells are short (<500 nt) and exist in a 
subset of genes involved in cell cycle and apoptosis. (A) Retained introns in control siRNA-, Y14 
siRNA-treated HeLa cells and RefSeq were grouped by length and plotted as a ratio to the total 
introns; and (B) gene ontology (GO) analysis indicated the functions of 483 genes that showed intron 
retention inY14 siRNA-treated HeLa cells. 
Next, we investigated the biological function of the 483 genes, containing 626 introns in the IRR 
high score group. We found that the enriched functional categories are related to mitotic cell cycle 
progression, including mitotic cell cycle (33/483), cell cycle check point (17/483), negative regulation 
of ubiquitin-protein ligase activity in mitotic cell cycle (11/483), anaphase-promoting 
complex-dependent proteasomal ubiquitin-dependent protein catabolic process (12/483), and 
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (11/483) (Figure 3B and 
Supplementary Table S3). Therefore, we assumed that intron retention might disrupt proper cell 
cycle progression in Y14-knockdown HeLa cells. Indeed, previous studies had shown that depletion 
of several EJC components induces the abnormal mitotic spindle formation, genome instability, and 
apoptosis [15,18]. Consistent with these observations, we found that Y14-knockdown caused 
abnormal nuclear structures and multinuclear phenotypes, which reflected a disruption of normal 
cell cycle progression (Supplementary Figure S2A). To examine cell cycle progression, we employed 
a FACS (fluorescence-activated cell sorting) analysis and found an increase in the population of cells 
at the G2/M and sub G0/G1 phases in Y14-knockdown HeLa cells (Supplementary Figure S2B). 
Furthermore, we investigated genome stability by staining Y14-knockdown cells with an antibody 
against Ser139-phosphorylated histone H2A.X (γH2A.X), the marker for double-strand DNA breaks, 
and we found that Y14-knockdown induced an increase in H2A.X foci (Supplementary Figure S2C). 
Taken together, we conclude that the EJC plays a crucial role for efficient and faithful pre-mRNA 
splicing of the genes that are involved in mitosis and genome stability. 
2.3. The Binding of the EJC Core Is Required for Splicing Activation of a Model Pre-mRNA 
The EJC is usually forms onto spliced mRNA, however, our implication of the EJC in splicing 
postulates its association with pre-mRNA. To examine whether the assembly of the EJC core onto 
Figure 3. A majorit f r t ined introns in Y14 knockdown cells are short (<500 nt) and exist in a
subset of genes involved in cell cycle and apoptosis. (A) Retained introns in control siRNA-, Y14
siRNA-treated HeLa cells and RefSeq were grouped by length and plotted as a ratio to the total introns;
and (B) gene ontology (GO) analysis indicated the functions of 483 genes that showed intron retention
inY14 siRNA-treated HeLa cells.
Next, we investigated the biological function of the 483 gen s, containing 626 introns in the
IRR high score group. We found that the enriched functional categories ar related to mitotic cell
cycle progression, including mitotic cell cycle (33/483), cell cycle check point (17/483), negative
regulation of ubiquitin-protein ligase activity in mitotic cell cycle (11/483), anaphase-promoting
complex-dependent proteasomal ubiquitin-dependent protein catabolic process (12/483), and
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (11/483) (Figure 3B and
Supplementary Table S3). Therefore, we assumed that intron retention might disrupt proper cell cycle
progression in Y14-knockdown HeLa cells. Indeed, previous studies had shown that depletion
of seve al EJC components i uces the abnormal mitotic spindle formation, genome instability,
and apoptosis [15,18]. Consist with th se observations, we found that Y14-knockdown caused
abnormal n clear structures and multinuclear phe otypes, which reflected a disrupti n of normal
cell cycle progression (Supplementary Figure S2A). To examine cell cycle progression, we employed a
FACS (fluorescence-activated cell sorting) analysis and found an increase in the population of cells
at the G2/M and sub G0/G1 phases in Y14-knockdown HeLa cells (Supplementary Figure S2B).
Furthermore, we investigated genome stability by staining Y14-knockdown cells with an antibody
against Ser139-phosphorylated histone H2A.X (γH2A.X), the marker for double-strand DNA breaks,
and we found that Y14-knockdown induced an increase in H2A.X foci (Supplementary Figure S2C).
Taken together, we conclude that the EJC plays a rucial r le for efficient and faithful pre-mRNA
splicing of the genes that are involved in mitosis and genome stability.
2.3. The Binding of the EJC Core Is Required for Splicing Activation of a Model Pre-mRNA
The EJC is usually forms onto spliced mRNA, however, our implication of the EJC in splicing
postulates its association with pre-mRNA. To examine whether the assembly of the EJC core onto
Int. J. Mol. Sci. 2016, 17, 1153 6 of 13
pre-mRNA is required for the efficient splicing of Y14-knockdown responsive introns, we used the
PSMB4 (proteasome subunit, β type 4) gene as a model [19]. The PSMB4 intron 5 is a typical short intron
(186 nt), which is retained in Y14- and eIF4AIII-knockdown HeLa cells (Figure 1A and Supplementary
Figure S1). We first confirmed the Y14 association with PSMB4 pre-mRNA containing intron 5 by
immunoprecipitation using the Y14 antibody. As expected, Y14 strongly associated with the intron
5-harboring pre-mRNA as well as the intron 5-excised mRNA. On the other hand, the translation
initiation factor eIF4E only associated with the spliced mRNA (Figure 4A). These results suggested
that the EJC is indeed formed on PSMB4 pre-mRNA.
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Figure 4. Core EJC assembly is required for increased splicing efficiency of the mini-PSMB4 model
pre-mRNA. (A) Whole HeLa cell extracts were subjected to immunoprecipitation (IP) using anti-Y14
or anti-eIF4E antibody in the absence of RNase A. Total RNAs (5% of input) and co-precipitated
RNAs were analyzed by RT–PCR using primer sets for PSMB4 (E5–E6) and ACTG1 (E3–E4).
The schematic representation on the right indicates the corresponding unspliced- and spliced-products.
Asterisk (*) indicates non-specific PCR products; (B) The schematic representation of a model PSMB4
exon 5–exon 6 pre-mRNA fused with five BoxB sites in the downstream of exon 6. The HA-λN tagged
EJC core components (eIF4AIII, Y14 and MAGOH) are represented by the oval; (C) Western blot
analysis of expressed HA-λN fusion proteins and endogenous UPF1 protein. UPF1 siRNA-treated
HeLa cells were transfected with the PSMB4 E5 E6-5ˆBoxB mini-gene plasmids and the indicated
HA-λN-tagg EJC component plasmids; (D) RT–PCR ana ysis was performed to detect the unspliced-
and spliced-products from the PSMB4 E5–E6 mini-gene. All experiments wer independently repeated
three times. Averages and standard deviations of the relative amou t of spliced mRNA are shown in
the right panel; and (E,F) the same tethering experiments as (C,D) using Y14 siRNA-treated HeLa cells.
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We next investigated whether the EJC could increase the splicing efficiency of PSMB4 pre-mRNA
with intron 5. We employed a tethering assay using the λN-BoxB system, which uses the λN peptide
to tether the protein of interest to RNAs [20]. We constructed the PSMB4 exon 5–exon 6 mini-gene
fused with five copies of BoxB sequences at the 3’ terminus of exon 6 and the effecter plasmids
encoding HA-λN tagged EJC core components (eIF4AIII, Y14 or MAGOH) (Figure 4B). To prevent
the NMD-degradation of RNA products from the PSMB4 mini-gene during this tethering assay,
we performed the experiment in the context of siRNA-mediated UPF1 knockdown that represses
NMD [20]. Western blotting was performed to check the protein expression levels of HA-λN tagged
EJC components as well as the depletion efficiency of endogenous UPF1. The experiments showed that
protein expression level of HA-λN-eIF4AIII was higher than those of HA-λN-Y14 and HA-λN-MAGOH
under the efficient depletion of endogenous UPF1 (Figure 4C). We then performed RT–PCR to examine
the splicing efficiency of the PSMB4 reporter transcript. Splicing efficiency was increased when
the pre-mRNA was tethered with the EJC core components (Figure 4D). We observed that splicing
activation by eIF4AIII (approximately five-fold increase compared to HA-λN control) was higher
than that caused by Y14 or MAGOH (approximately two-fold increase compared to HA-λN control).
It is thus likely that this difference of splicing activation was due to the expression levels of the
tethered proteins. In these tethering experiments, we assume that one of the tethered EJC core factors
(eIF4AIII, Y14, or MAGOH) would be able to associate with the rest of the endogenous EJC core factors.
Next, we performed the tethering of eIF4AIII or MAGOH to PSMB4 reporter transcripts in
Y14-knockdown HeLa cells, where it was expected that neither tethered eIF4AIII nor MAGOH could
form the EJC core. Western blot analysis confirmed the protein expression levels of HA-λN-eIF4AIII
and HA-λN-MAGOH, and the depletion of endogenous Y14 (Figure 4E). RT–PCR analysis revealed
that splicing efficiencies of PSMB4 reporter transcripts tethered with eIF4AIII or MAGOH were no
longer enhanced in the absence of Y14 (Figure 4F). These results suggest that the EJC core formation
on pre-mRNA is a prerequisite for observed splicing activation.
2.4. RNPS1 Is a Key Factor in EJC Core-Mediated Splicing Activation
Our results indicated that the EJC core recruits a trans-acting factor to activate splicing. The EJC
core has been reported to associate with accessory factors involved in pre-mRNA splicing, mRNA
export, NMD, and translation (reviewed in [1]). To identify the EJC-recruited accessory proteins
that promote the efficient splicing, we performed siRNA-mediated knockdown of RNPS1 (splicing
activator/regulator) and UPF1 (essential NMD factor). Western blot analysis confirmed that Y14,
RNPS1 and UPF1 were efficiently depleted (Figure 5A). Interestingly, RT–PCR analysis showed that
RNPS1 knockdown induced the retention of several (Figure 5B), but not all (Figure 5C), Y14-knockdown
responsive introns (Figure 5B). In contrast, UPF1 knockdown did not induce intron retention, indicating
that intron retentions by Y14 or RNPS1 knockdown are not due to the survival of transcript generated
by the loss of NMD function. In addition, we checked the transcripts of MDM2, AURKB and ACTG1
by RT–PCR in RNPS1- or UPF1-knockdown HeLa cells. Here, we observed abnormal transcripts of
MDM2 and AURKB (both contain Y14-knockdown responsive introns) and concomitant reduction of
AURKB protein level in RNPS1-knockdown cells (Supplementary Figure S3A,B,D). In contrast, we
detected only the full-length transcript of ACTG1 (contains control Y14-knockdown nonresponsive
intron) (Supplementary Figure S3C). These results strongly suggest that RNPS1 interacts with the
EJC core and promotes the efficient and faithful pre-mRNA splicing of the target Y14-knockdown
responsive introns.
3. Discussion
It has been recently shown that knockdown of the EJC core factor causes global alternative splicing
changes in mammalian cells [21]. Our Y14-knockdown experiments followed by RNA-Seq analysis
uncover an important new aspect of the EJC core function. We found that the EJC core contributes, not
only to the efficiency, but also to the fidelity of constitutive splicing in a set of functionally related genes.
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3.1. The EJC as a Master Splicing Controller of Genes Involved in Cell Cycle Progression
The EJC was documented to have multiple roles in the post-splicing events of mammalian
gene expression (reviewed in [1]). Here, we demonstrate that the EJC core component Y14 is
required for the efficient splicing of target introns in many genes involved in mitotic cell cycle
progression. The Y14-knockdown derived intron-retention events were also accompanied by a variety
of aberrant splicing, such as alternative splice site usage and exon skipping. The generation of these
abnormal transcripts naturally leads to a reduction of the full-length transcripts. The abnormal
transcripts may often be dead-end mRNAs that are destined to be degraded or they may even produce
antagonistic or dominant negative proteins, which disturb correct itotic cell cycle progression.
Consistently, it was previously show that depletion of Y14 results in G2/M cell cycle arrest followed
by apoptosis [22]. Here, we observ d that Y14 knockdown in HeL c lls induces abnormal uclear
structure, multinucleated cells, G2/M cell cycle arrest, and genome instability.
We identified various abnormal transcripts of AURKB (Aurora B kinase) and MDM2 (murine
double minute 2) genes in Y14-knockdown HeLa cells. AURKB, a serine/threonine kinase, functions
in chromosome segregation, cleavage of polar spindle microtubules and cytokinesis [23]. Inhibition of
the AURKB function in mitotic cells causes misaligned chromosomes and defective cytokinesis, which
results in polyploidy (ě4N cells) [23,24]. MDM2 possesses E3 ubiquitin ligase activity that targets P53,
and MDM2 knockout in mouse germ line causes embryonic leth lity at the blastocyst stage due to
inappropriate apoptosis [25–27]. Thus, the known functions of MDM2 and AURKB would be able to
explain a part of the ph notype caused by Y14 knockdown.
The changes in transcript level, alternative splicing, and protein level in the core EJC-deficient
cells were reported to cause the disruption of proper cell cycle progression and the apoptosis process,
which is indeed consistent with our results. Mouse Magoh mutant haplo-insufficiency causes the defect
of mitosis of neural stem cells and apoptosis, which are rescued by restoring the expression of Lis1, a
microtubule-associated protein essential for mitotic spindle integrity [18]. Moreover, a recent study
demonstrated that the EJC components regulate the alternative splicing of several apoptotic genes; i.e.,
knockdown of the EJC core (Y14 and eIF4AIII) or splicing-related EJC peripheral (RNPS1, ACINUS and
SAP18) proteins increases the production of the pro-apoptotic splice variant of Bcl-xS pre-mRNA [15].
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Taking our findings and these studies together, we conclude that the EJC plays an important role in the
expression of genes involved in proper cell cycle progression and apoptosis.
3.2. Molecular Mechanisms of EJC-Mediated Splicing Regulation
We found that the EJC core factor, Y14, controls splicing of a specific group of short-intron.
Using the model PSMB4 pre-mRNA harboring intron 5 (186 nt), we showed that the EJC deposition
near the intron is critical to stimulating splicing activity. Recent studies in Drosophila also indicated
that efficient splicing of the piwi pre-mRNA containing intron 4 is promoted by RnpS1 and Acinus,
which are recruited by the pre-deposited EJC at adjacent spliced exon junctions [28,29].
It was proposed that pre-mRNA splicing of short introns occurs by the formation of a splicing
complex across the introns (termed “intron definition”), whereas that of long intron, a cross-exon
splicing complex is formed (termed “exon definition”) prior to the splicing of adjacent introns [30,31].
Therefore, the deposit of the EJC may underpin precise short intron recognition and formation of
a stable intron definition complex. Previously, it was shown that the EJC associates with several
splicing regulators such as RNPS1, PININ, ACINUS, and SAP18, which contain specific domains
that are capable of interacting with general splicing factors (reviewed in [1]). Here, we demonstrate
that the EJC-peripheral factor, RNPS1 at least, is the trans-acting factor for the efficient splicing of
pre-mRNAs containing Y14-knockdown responsive short introns. On the other hand, RNPS1 was
reported to be associated with SAP18 and ACINUS, to form the apoptosis and splicing-associated
protein (ASAP) complex [8]. Moreover, a recent structural analysis revealed that RNPS1 and SAP18
are able to interact with PININ, forming another ternary complex, PSAP [14]. Therefore, it remained to
be elucidated whether RNPS1 solely or RNPS1 complex, such as ASAP (PSAP), is responsible for the
EJC core mediated splicing activation.
Taken together, we propose the model that the initial deposition of the EJC core at adjacent
(upstream and/or downstream) spliced junctions recruits EJC-peripheral splicing regulator(s), either
RNPS1 alone or in the ASAP (PSAP) complex, to promote the efficient or stable formation of intron
definition complexes on the proximate short intron (Figure 6). This finding provides a mechanistic
link between the originally identified RNPS1 as a general splicing activator/regulator [2,3] and the
detection of RNPS1 as a peripheral component of the EJC (reviewed in [1]).
Interestingly, we observed pre-mRNA splicing activation, not inhibition, by the Y14-knockdown
experiment in another specific subset of pre-mRNAs, suggesting EJC-mediated repression rather than
activation of splicing. In this opposite case, it will be interesting to ascertain what is the trans-acting
factor recruited by EJC core to promote splicing repression. We wish to propose that the EJC core
as potential master splicing controller with potential to recruit splicing regulators, either positive or
negative, to define distinct splicing activity modes.
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4. Experimental Procedures
4.1. Plasmid Constructions and Antibodies
To construct pCS2-HA-λN-eIF4AIII, pCS2-HA-λN-Y14, and pCS2 -HA-λN-MAGOH, cDNAs
were amplified by PCR and subcloned into pCS2-HA-λN vector as previously described [32].
Five contiguous copies of the BoxB sequence were amplified by PCR from pCS2+Rluc-BoxB [32],
and cloned into pcDNA3 (Thermo Fisher Scientific, Waltham, MA, USA). The pcDNA3-PSMB4-5BoxB
mini-gene was obtained by subcloning PCR-amplified HeLa genomic DNA containing the exon 5,
intron 5 and exon 6 region into the pcDNA3-5BoxB vector. The following antibodies were commercially
available: anti-Y14 (Sigma, St. Louis, MO, USA), anti-UPF1 and anti α-tubulin (Cell Signaling
Technology, Danvers, MA, USA), and anti-MDM2 and anti-AURKB (Abcam, Cambridge, UK).
The anti-RNPS1 antibody was previously described [2].
4.2. Cell Culture and siRNA Knockdown
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum. ON-TARGET plus SMART pool siRNA reagents and negative control siRNA (GE
Healthcare, Chicago, IL, USA) were used to knockdown the expression of Y14, RNPS1 and UPF1.
Transfection of the siRNA was performed with Lipofectamine RNAiMax (Thermo Fisher Scientific)
according to the manufacture’s protocol. HeLa cells were grown in 35 mm dishes and transfected with
each siRNA (100 pmol). At 48 h post-transfection, total proteins and RNAs were isolated from the
siRNA-treated HeLa cells using ISOGEN (Wako, Kyoto, Japan).
4.3. RNA-Seq Analysis
For RNA-Seq, mRNA isolation and DNA library preparation were performed according to
the manufacturer’s protocol (Illumina, San Diego, CA, USA). The DNA libraries were prepared
from four independent RNA sources; HeLa cells treated with two control siRNAs and two Y14
siRNAs. These samples were sequenced on a high-throughput platform (HiSeq2000, Illumina)
using a 76 bp single-end strategy. The reads were mapped onto the hg19 human genome
sequences using the TopHat 1.12.0 (https://ccb.jhu.edu/software/tophat/index.shtml). All positions
of junctions contained in the mapping results were annotated as an intron in the ENSEMBL
annotation database (http://asia.ensembl.org/index.html). Our RNA-Seq analysis is shown in
Supplementary Experimental Procedures. RNA-Seq raw data have been deposited in DDBJ database
(http://www.ddbj.nig.ac.jp/index-e.html) under accession No. DRA004068.
4.4. Tethering Experiments
For the tethering assays, 0.1 µg of pcDNA3-PSMB4-5BoxB with 0.5 µg of pCS2-HA-λN-eIF4AIII,
pCS2-HA-λN-Y14 or pCS2-HA-λN-MAGOH were co-transfected into UPF1 siRNA- or Y14
siRNA-treated HeLa cells in 35 mm dishes, using PolyFect transfection reagent (QIAGEN, Venlo,
The Netherlands). Transfected HeLa cells were cultured for 24 h before extraction of proteins and RNAs.
Expression level of HA-λN fusion proteins and endogenous UPF1 or Y14 protein were examined by
Western blotting. To analyze splicing products from the PSMB4 mini-gene, total RNA from transfected
cells were analyzed by RT–PCR using T7 and PSMB4-E6AS-XhoI primers (Supplementary Table S4).
PCR products were analyzed by 1.5% or 2% agarose gel electrophoresis. Splicing products were
quantified using NIH Image J software (https://imagej.nih.gov/ij/) [33,34].
4.5. Immunoprecipitation Experiments
For immunoprecipitation of Y14 and eIF4E-associated mRNA, whole HeLa cell extracts were
prepared and mixed with antibodies conjugated with Dynal beads protein G (Invitrogen, Carlsbad, CA,
USA) in NET2 buffer [35]. After a 3 h incubation at 4 ˝C, the beads were washed six times with NET2
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buffer and bound RNA was recovered by phenol extraction and ethanol precipitation. The precipitated
RNAs were analyzed by RT–PCR.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/17/8/
1153/s1.
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